arcoris bio
2 known investors
Find your way into arcoris bio
Sign up to see every warm intro you have to arcoris bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the arcoris bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.
Founders & leadership
SR

Simon RestrepoSimon Restrepo is co-founder of Arcoris Bio, which develops multiplex biomarker detection technology using nanotechnology and signal amplification for biomedical research and diagnostics applications.
KB

Kaspar BinzKaspar Binz is an engineer with over 20 years of experience in biologics and biotech company development. He is co-founder and CEO of Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.
SF

Scott FraserScott Fraser holds a B.S. in physics from Harvey Mudd College and a Ph.D. in biophysics from Johns Hopkins University. He has spent his career in academic research and leadership roles, including positions at UC Irvine, Caltech, and USC, with expertise in imaging, molecular analysis, and early-stage biological systems, and he now leads Arcoris Bio, which develops multiplex biomarker detection technology for biomedical research and diagnostics.
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeed FundingNov 2025 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does arcoris bio do?
- Arcoris Bio develops multiplex biomarker detection technology for researchers and clinicians in biomedical research and diagnostics. The company's MUSE technology enables precise, sensitive detection of multiple biomarkers across fields including cancer, immunology, neuroscience, and pharmaceutical research.
- Who founded arcoris bio?
- arcoris bio was founded by Simon Restrepo, Kaspar Binz, Scott Fraser.
- Who are arcoris bio's investors?
- arcoris bio's investors include Ventura BioMed Investors, ZEISS Ventures.

